Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R McDevitt

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2016
Remodeling the Vascular Microenvironment of Glioblastoma with α-ParticlesKatja Behling, William F Maguire, Valentina Di Gialleonardo, et al.
Biomaterials|March 3, 2020
Targeted melanoma radiotherapy using ultrasmall <sup>177</sup>Lu-labeled α-melanocyte stimulating hormone-functionalized core-shell silica nanoparticlesXiuli Zhang, Feng Chen, Melik Z Turker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2021
[<sup>89</sup>Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2022
Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
Science (New York, N.Y.)|November 17, 2001
Tumor therapy with targeted atomic nanogeneratorsM R McDevitt, D Ma, L T Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-LintuzumabTodd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2010
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemiaTodd L Rosenblat, Michael R McDevitt, Deborah A Mulford, et al.
Blood|August 1, 2002
Targeted alpha particle immunotherapy for myeloid leukemiaJoseph G Jurcic, Steven M Larson, George Sgouros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2018
Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast CancerDaniel L J Thorek, Anson T Ku, Nicholas Mitsiades, et al.
Scientific Reports|July 29, 2022
[<sup>18</sup>F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy responseHanwen Zhang, Diane Abou, Peng Lu, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2016
Remodeling the Vascular Microenvironment of Glioblastoma with α-ParticlesKatja Behling, William F Maguire, Valentina Di Gialleonardo, et al.
Biomaterials|March 3, 2020
Targeted melanoma radiotherapy using ultrasmall <sup>177</sup>Lu-labeled α-melanocyte stimulating hormone-functionalized core-shell silica nanoparticlesXiuli Zhang, Feng Chen, Melik Z Turker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2021
[<sup>89</sup>Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2022
Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
Science (New York, N.Y.)|November 17, 2001
Tumor therapy with targeted atomic nanogeneratorsM R McDevitt, D Ma, L T Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-LintuzumabTodd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2010
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemiaTodd L Rosenblat, Michael R McDevitt, Deborah A Mulford, et al.
Blood|August 1, 2002
Targeted alpha particle immunotherapy for myeloid leukemiaJoseph G Jurcic, Steven M Larson, George Sgouros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2018
Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast CancerDaniel L J Thorek, Anson T Ku, Nicholas Mitsiades, et al.
Scientific Reports|July 29, 2022
[<sup>18</sup>F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy responseHanwen Zhang, Diane Abou, Peng Lu, et al.
Pageof 12